-
Something wrong with this record ?
Permeation enhancers in transdermal drug delivery: benefits and limitations
A. Kováčik, M. Kopečná, K. Vávrová,
Language English Country Great Britain
Document type Journal Article, Research Support, Non-U.S. Gov't, Review
- MeSH
- Administration, Cutaneous MeSH
- Skin Absorption * MeSH
- Skin metabolism MeSH
- Pharmaceutical Preparations administration & dosage metabolism MeSH
- Drug Delivery Systems MeSH
- Humans MeSH
- Permeability MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Review MeSH
Introduction: Transdermal drug delivery has several clinical benefits over conventional routes of drug administration. To open the transdermal route for a wider range of drugs, including macromolecules, numerous physical and chemical techniques to overcome the natural low skin permeability have been developed.Areas covered: This review focuses on permeation enhancers (penetration enhancers, percutaneous absorption promoters or accelerants), which are chemicals that increase drug flux through the skin barrier. First, skin components, drug permeation pathways, and drug properties are introduced. Next, we discuss properties of enhancers, their various classifications, structure-activity relationships, mechanisms of action, reversibility and toxicity, biodegradable enhancers, and synergistic enhancer combinations.Expert opinion: Overcoming the remarkable skin barrier properties in an efficient, temporary and safe manner remains a challenge. High permeation-enhancing potency has long been perceived to be associated with toxicity and irritation potential of such compounds, which has limited their further development. In addition, the complexity of enhancer interactions with skin, formulation and drug, along with their vast chemical diversity hampered understanding of their mechanisms of action. The recent development in the field revealed highly potent yet safe enhancers or enhancer combinations, which suggest that enhancer-aided transdermal drug delivery has yet to reach its full potential.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20028550
- 003
- CZ-PrNML
- 005
- 20210114154226.0
- 007
- ta
- 008
- 210105s2020 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1080/17425247.2020.1713087 $2 doi
- 035 __
- $a (PubMed)31910342
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Kováčik, Andrej $u Skin Barrier Research Group, Faculty of Pharmacy in Hradec Králové, Charles University, Hradec Králové, Czech Republic.
- 245 10
- $a Permeation enhancers in transdermal drug delivery: benefits and limitations / $c A. Kováčik, M. Kopečná, K. Vávrová,
- 520 9_
- $a Introduction: Transdermal drug delivery has several clinical benefits over conventional routes of drug administration. To open the transdermal route for a wider range of drugs, including macromolecules, numerous physical and chemical techniques to overcome the natural low skin permeability have been developed.Areas covered: This review focuses on permeation enhancers (penetration enhancers, percutaneous absorption promoters or accelerants), which are chemicals that increase drug flux through the skin barrier. First, skin components, drug permeation pathways, and drug properties are introduced. Next, we discuss properties of enhancers, their various classifications, structure-activity relationships, mechanisms of action, reversibility and toxicity, biodegradable enhancers, and synergistic enhancer combinations.Expert opinion: Overcoming the remarkable skin barrier properties in an efficient, temporary and safe manner remains a challenge. High permeation-enhancing potency has long been perceived to be associated with toxicity and irritation potential of such compounds, which has limited their further development. In addition, the complexity of enhancer interactions with skin, formulation and drug, along with their vast chemical diversity hampered understanding of their mechanisms of action. The recent development in the field revealed highly potent yet safe enhancers or enhancer combinations, which suggest that enhancer-aided transdermal drug delivery has yet to reach its full potential.
- 650 _2
- $a aplikace kožní $7 D000279
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a lékové transportní systémy $7 D016503
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a permeabilita $7 D010539
- 650 _2
- $a léčivé přípravky $x aplikace a dávkování $x metabolismus $7 D004364
- 650 _2
- $a kůže $x metabolismus $7 D012867
- 650 12
- $a kožní absorpce $7 D012869
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Kopečná, Monika $u Skin Barrier Research Group, Faculty of Pharmacy in Hradec Králové, Charles University, Hradec Králové, Czech Republic.
- 700 1_
- $a Vávrová, Kateřina $u Skin Barrier Research Group, Faculty of Pharmacy in Hradec Králové, Charles University, Hradec Králové, Czech Republic.
- 773 0_
- $w MED00193514 $t Expert opinion on drug delivery $x 1744-7593 $g Roč. 17, č. 2 (2020), s. 145-155
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31910342 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20210105 $b ABA008
- 991 __
- $a 20210114154223 $b ABA008
- 999 __
- $a ok $b bmc $g 1608885 $s 1119730
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 17 $c 2 $d 145-155 $e 20200114 $i 1744-7593 $m Expert opinion on drug delivery $n Expert Opin Drug Deliv $x MED00193514
- LZP __
- $a Pubmed-20210105